Please turn JavaScript on
Biotech Investments icon

Biotech Investments

Receive updates from Biotech Investments for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from Biotech Investments. Unsubscribe at any time.

Site title: Biotech Investments – Independent Medical Rating Agency for Biotech and Pharmaceutical Assets. Purpose-built for Investors and Industry Partners.

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  5.71 / day

Message History

Medios AG

Medios AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

13.08.2026 / 17:30 CET/CEST

Dissemination of a Voting Rights Announcement transmitted by


Read full story

Medios AG

Medios AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

13.08.2026 / 17:30 CET/CEST

Dissemination of a Voting Rights Announcement transmitted by


Read full story

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

13.08.2026 / 10:00 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated<...


Read full story

Cantourage Group SE

/ Key word(s): Interim Report/Quarter Results

Cantourage Group SE increases EBITDA by 45 percent in the second quarter of 2026 – strategic focus on high-margin business pays off

13.08.2026 / 08:00 CET/CEST

The issuer is solely responsible for the content of this announcement.

Gross margin rises to 36.4% an...

Read full story